Suggestions
Andrew W. Lam, PharmD
Investor in life.
Andrew W. Lam, PharmD, is a prominent figure in the biotech and private equity sectors, currently serving as the Managing Director and Head of Biotech Private Equity at Ally Bridge Group. He is also a Board Member at Endeavor Biomedicines. Based in New York, Lam has extensive experience in the pharmaceutical and biotechnology industries, focusing on investments and strategic development.
In his role at Ally Bridge, he has been involved in various initiatives and collaborations aimed at advancing healthcare solutions. His professional background includes significant contributions to the field of drug development and commercialization, particularly in oncology and antibody-drug conjugates.123
Lam holds a Doctor of Pharmacy (PharmD) degree, which complements his expertise in both clinical and business aspects of the pharmaceutical industry. His leadership and strategic insights are recognized within the biotech community, making him a key player in shaping the future of biomedicine.12
